Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression inTransthyretin (ATTR) Amyloidosis
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence…
Intellia Announces First Clinical Evidence from Ongoing Phase 1 Study that Nexiguran Ziclumeran (nex-z), an In Vivo CRISPR/Cas9-Based Gene Editing Therapy, May Favorably Impact Disease Progression inTransthyretin (ATTR) Amyloidosis
Consistently rapid, deep and durable reduction in serum TTR accompanied by evidence…
Bavarian Nordic Announces Interim Results for the First Nine Months of 2024
COPENHAGEN, Denmark, November 15, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced…
Sweden becomes first country in the world to apply for Trademark
The application comes as Visit Sweden looks to Prevent Travel Mix-Ups Among…
Silverfort Acquires Rezonate, Expanding its Cloud Identity Security Offering to Deliver the First Complete Identity Security Platform
With Rezonate's acquisition, Silverfort continues to break down identity security silos across…
Sweden becomes first country in the world to apply for Trademark
The application comes as Visit Sweden looks to Prevent Travel Mix-Ups Among…
Alliance University Awarded A+ Accreditation by NAAC in First Assessment Cycle
This A+ accreditation achievement is reflected in the varsity's cumulative CGPA of…
India IVF, one of India’s First Tech-Enabled Fertility Platform, Secures $1.25 Million Investment from Tomorrow Capital
GURGAON, India, Nov. 11, 2024 /PRNewswire/ -- India IVF, a pioneering fertility provider…
ALK licenses rights to neffy, the first approved adrenaline nasal spray for emergency treatment of allergic reactions (anaphylaxis)
ALK (ALKB:DC / OMX: ALK B) today announced that it has entered…
Approx. USD 4.0 M Invested in Product Development for NTDs – GHIT’s First Investment in the Development of Diagnostics for Trachoma
TOKYO, Nov. 7, 2024 /PRNewswire/ -- The Global Health Innovative Technology (GHIT)…